- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Divi's Laboratories Ltd. (DIVI)
Track today's live Divi's Labs (DIVI) share price, performance and key data on this page with our current NSE:DIVI stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Divi's Labs share price on the NSE exchange. Use the dropdown to switch exchange for the DIVI share price, head to our technical summary section, which provides analysis on Divi's Labs share price buy/sell indicators using real-time data (or discuss the Divi's Labs (DIVI) stock price today with other investors in the Divi's Labs NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:DIVI share price (ISIN: INE361B01024) to enhance your trading decisions with our free investment tools and resources.
What Is the Divi's Laboratories Ltd. Share Price Today?
The Divi's Labs share price today is 8,477.00.
What Is the Stock Symbol for Divi's Laboratories Ltd.
The stock symbol (or 'ticker') for Divi's Laboratories Ltd. is "DIVI."
What Stock Exchange Does Divi's Laboratories Ltd. Trade On?
Divi's Laboratories Ltd. is listed and trades on the NSE stock exchange.
Is Divi's Laboratories Ltd. a Good Stock to Buy?
Determining whether Divi's Labs (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:DIVI share price (ISIN: INE361B01024) to enhance your trading decisions with our free investment tools and resources.
What Is the Divi's Laboratories Ltd. Share Price Today?
The Divi's Labs share price today is 8,477.00.
What Is the Stock Symbol for Divi's Laboratories Ltd.
The stock symbol (or 'ticker') for Divi's Laboratories Ltd. is "DIVI."
What Stock Exchange Does Divi's Laboratories Ltd. Trade On?
Divi's Laboratories Ltd. is listed and trades on the NSE stock exchange.
Is Divi's Laboratories Ltd. a Good Stock to Buy?
Determining whether Divi's Labs (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Currency in INR
8,477.00
-23.00(-0.27%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,465.50
8,574.50
52 wk Range
5,636.50
8,674.00
DIVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,465.508,574.50
52 wk Range
5,636.508,674.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.35%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DIVI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
8,292.48
Downside
-2.18%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
13 Buy
6 Hold
10 Sell
Ratings:
29 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 8,292.48
(-2.18% Downside)
Divi's Laboratories Ltd. Earnings Call Summary for Q1/2027
- Divi's Laboratories Q1 FY2026 revenue rose 24.3% YoY to INR 3,144 crores; profit after tax surged 65.5% to INR 902 crores on favorable mix.
- Custom synthesis drove 60% of quarterly revenue; management reaffirmed double-digit revenue growth target for full FY2027 despite quarterly volatility.
- Three major capex projects are 70% complete at INR 2,000 crores total cost; peptide capacity expansion and backward integration underway.
- Full-year gross margin expected around 60% vs. 68% in Q1; EBITDA margin to remain similar to prior year with quarterly fluctuations anticipated.
- Stock rose 2.82% to $8,056, near 52-week high; risks include raw material inflation, high inventory levels, and elevated valuation multiples.
Last Updated: 01/08/2026, 10:46
Read Full TranscriptEarnings
Latest Release
03/08/2026
EPS / Forecast
33.95 / 24.88
Revenue / Forecast
30.8B / 27.7B
Compare DIVI to Peers and Sector
Metrics to compare | DIVI | Peers Peers - average of corresponding metrics from companies closely matching DIVI: LAURUSLABS, CIPLA, SAILIFE, AKUMS, TORNTPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDIVIPeersSector |
|---|---|---|---|---|
P/E Ratio | 76.9x | 38.6x | −0.4x | |
PEG Ratio | 2.85 | 0.72 | 0.00 | |
Price/Book | 13.4x | 3.6x | 2.6x | |
Price / LTM Sales | 20.0x | 3.8x | 3.1x | |
Upside (Analyst Target) | −1.4% | 6.2% | 47.8% | |
Fair Value Upside | Unlock | −0.4% | 6.2% | Unlock |
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Divi's Labs (NSE: DIVI) Share Price Today?
The Divi's Labs stock price today is 8,477.00 INR.
What Stock Exchange Does Divi's Labs (DIVI) Trade On?
Divi's Labs is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Divi's Labs?
The stock symbol (also called a 'ticker') for Divi's Labs is "DIVI."
Does Divi's Labs Pay Dividends? What’s The Current DIVI Dividend Yield?
Yes, DIVI Pays Dividends to its Shareholders. The current Divi's Labs dividend yield is 0.35%.
What Is the Current Divi's Labs Market Capitalisation?
As of today, Divi's Labs (NSE: DIVI) market cap is 2.25T INR.
What Is Divi's Labs's (DIVI) Earnings Per Share (TTM)?
The Divi's Labs EPS is currently 110.21 (Trailing Twelve Months).
When Is the Next Divi's Labs Earnings Date?
Divi's Labs's next earnings report will be released on 09/11/2026.
Is DIVI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Divi's Labs moving averages and other technical indicators, the daily buy/sell signal for DIVI stock is Strong Buy.
How Many Times Has Divi's Labs Stock Split?
Divi's Labs has split 3 times. (See the DIVI stock split history page for full effective split date and price information.)
How Many Employees Does Divi's Labs Have?
Divi's Labs has 11565 employees, based on their latest Companies House report.
What is the current trading status of Divi's Labs (NSE: DIVI)?
As of 16/08/2026, Divi's Labs (DIVI) is trading at a share price of 8,477.00 INR, with a previous close of 8,500.00 INR. The stock has fluctuated within a day range of 8,465.50 INR to 8,574.50 INR, while its 52-week range spans from 5,636.50 INR to 8,674.00 INR.
What Is Divi's Labs (DIVI) Price Target According to Analysts?
The average 12-month price target for Divi's Labs is 8,292.48 INR, with a high estimate of 11700 INR and a low estimate of 6000 INR. 13 analysts recommend buying the stock, while 10 suggest selling, leading to an overall rating of Neutral. The stock has an -2.18% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.